Russell Investments Group, Ltd. G1 Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$10.16 - $16.17 $1.59 Million - $2.53 Million	-156,507 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$13.16 - $22.47 $2.06 Million - $3.52 Million	156,507 New	156,507 $2.1 Million
Q2 2021 Aug 04, 2021	SELL	$19.57 - $26.32 $741,096 - $996,712	-37,869 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$17.58 - $32.59 $119,702 - $221,905	6,809 Added 21.92%	37,869 $909,000
Q4 2020 Feb 08, 2021	BUY	$10.99 - $20.4 $129,682 - $240,719	11,800 Added 61.27%	31,060 $558,000
Q3 2020 Nov 09, 2020	BUY	$11.55 - $23.75 $47,077 - $96,805	4,076 Added 26.84%	19,260 $222,000
Q1 2020 May 06, 2020	BUY	$9.07 - $26.32 $137,718 - $399,642	15,184 New	15,184 $167,000
Q1 2019 May 13, 2019	SELL	$14.4 - $21.45 $118,339 - $176,276	-8,218 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$16.51 - $51.33 $29,008 - $90,186	-1,757 Reduced 17.61%	8,218 $157,000
Q3 2018 Oct 26, 2018	SELL	$43.15 - $67.97 $1.71 Million - $2.69 Million	-39,629 Reduced 79.89%	9,975 $522,000
Q1 2018 May 11, 2018	BUY	$19.05 - $41.76 $135,750 - $297,581	7,126 Added 16.78%	49,604 $1.84 Million
Q4 2017 Feb 06, 2018	BUY	$19.01 - $26.2 $807,506 - $1.11 Million	42,478	42,478 $831,000

3.62M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.